Price (delayed)
$120.42
Market cap
$11.5B
P/E Ratio
77.19
Dividend/share
N/A
EPS
$1.56
Enterprise value
$12.7B
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going
There are no recent dividends present for SRPT.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.